Effect of 3-aminobenzamide, PARP inhibitor, on matrix metalloproteinase-9 level in plasma and brain of ischemic stroke model
- 1 October 2005
- journal article
- Published by Elsevier in Toxicology
- Vol. 214 (1-2), 131-139
- https://doi.org/10.1016/j.tox.2005.06.023
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Poly(ADP-Ribose) Polymerase-1 Promotes Microglial Activation, Proliferation, and Matrix Metalloproteinase-9-Mediated Neuron DeathThe Journal of Immunology, 2005
- Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor‐κB signalingInternational Journal of Cancer, 2004
- Effect of poly(ADP-ribose) polymerase inhibitors on oxidative stress evoked hydroxyl radical level and macromolecules oxidation in cell free system of rat brain cortexNeuroscience Letters, 2003
- Transcriptional Coactivation of Nuclear Factor-κB-dependent Gene Expression by p300 Is Regulated by Poly(ADP)-ribose Polymerase-1Journal of Biological Chemistry, 2003
- Poly(ADP‐ribose) polymerase‐1 activity promotes NF‐κB‐driven transcription and microglial activation: implication for neurodegenerative disordersJournal of Neurochemistry, 2003
- Matrix Metalloproteinases Increase Very Early during Experimental Focal Cerebral IschemiaJournal of Cerebral Blood Flow & Metabolism, 1999
- Neutrophil inhibitory factor treatment of focal cerebral ischemia in the ratBrain Research, 1998
- Polymorphonuclear Leukocyte Behavior in a Nonhuman Primate Focal Ischemia ModelJournal of Cerebral Blood Flow & Metabolism, 1994
- Reperfusion increases neutrophils and leukotriene B4 receptor binding in rat focal ischemia.Stroke, 1992
- Secretion of Collagenolytic Enzymes by Human Polymorphonuclear LeukocytesCollagen and Related Research, 1984